The global fertility services market size was worth USD 21,718 million in 2021. It is projected to reach USD 82,600 million by 2030, growing at a CAGR of 16% during the forecast period (2022–2030). Treatments that help patients with infertility include fertility services. Different infertility services, such as in-vitro fertilization (IVF), surrogacy, artificial insemination, and others, help infertile couples, single mothers, and the LGBT community have children. Due to the high prevalence of infertility problems, the growing tendency of women to delay pregnancies, the rise in technological improvements in fertility operations, and the rise in gamete donations, the global market for fertility services is anticipated to have significant expansion in the future. In addition, the availability of reproductive therapies, the rise in disposable income, and advantageous reimbursement regulations all contribute to the market's expansion.
Get more information on this report Download Sample Report
A rapid increase in the infertility rate is one of the significant factors that drive the growth of the fertility services market. One in every four couples in emerging nations is affected by infertility. According to macrotrends.net (2019), the global fertility rate in 2019 was 2.458 births per woman, a 0.41% decline from 2018. Furthermore, lifestyle habits such as smoking also affect fertility rates, including stress, nutrition, alcohol, obesity, etc. The rise in infertility rates is not only due to lifestyle changes but also to diseases such as sexually transmitted diseases (STDs) and fertility-related diseases. Hence, the increase in infertility rates in the near future is anticipated to augment the market's growth.
The trend of delayed pregnancy has steadily risen globally. In older women, the eggs produced by the reproductive system are immature for the process of fertilization with male spermatozoa. This may result in the risk of genetic disorders in the egg. Aging individuals witness a decline in the production of healthy eggs. Usually, few eggs are produced with low quality in older women.
All this can result in the egg facing the risk of genetic disorders. According to CDC, the pregnancy rate in the age group of 35–39 years has increased drastically, which further boosts the growth of the fertility services market.
Health insurance benefits in various countries do not cover ART procedures. The unavailability of insurance reimbursements for IVF treatments impedes market growth, especially in developing nations. Couples cannot afford the high costs of the ART and IVF procedures and hence limit the adoption of such technologies. According to CDC, 15 states have enacted legislation requiring private insurers to cover some or all of the costs of infertility treatments. The coverage varies by state, with only eight states mandating reimbursement for assisted reproductive technology (ART). The absence of fixed national reimbursement policies and plans is the main reason behind these inadequate reimbursements.
Fertility or reproductive tourism is the practice of traveling to other countries for fertility treatments. The critical reasons for fertility tourism are legal prohibitions, stringent regulations or non-availability of fertility procedures in the home country, and the lower costs coupled with technological advancements in fertility tourism destinations. However, it should be noted that different countries have different sets of regulations regarding fertility tourism; for instance, Costa Rica recently lifted a 16-year-old ban on IVF. Furthermore, since American infertility treatments have a greater success rate than those in Europe, Europeans prefer to travel to North America for fertility tourism.
Additionally, North America is favored for fertility tourism because of lax rules. The availability of lax laws related to in-vitro fertilization therapy has made Mexico a popular destination for fertility tourism. The top destination for fertility tourism in Israel. Leading locations for various infertility treatments include India and other Asian nations. In addition, egg donation is legal in several European countries, such as Italy and Germany. Thus, many women prefer to go to these European countries where they can be paid for egg donations. Fertility tourism promotes fertility services, especially in emerging markets, creating lucrative market growth opportunities.
The global fertility services market is segmented by procedure, service, end-user, and region.
Based on procedure, the global fertility services market is divided into IVF with Intracytoplasmic Sperm Injection (ICSI), Surrogacy, IVF without ICSI, Intrauterine Insemination (IUI), and Others.
IVF with ICSI procedure has the highest market share and is estimated to grow at a CAGR of 16.9% during the forecast period. The rise in delayed pregnancies in women is a vital factor boosting the market growth. Also, increase in technological advancements concerning fertility treatment, the surge in success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, and low sperm count in men, and rise in accessibility and availability of healthcare facilities, and an increase in healthcare and research expenditure are the major factors driving the growth of the fertility services market.
Furthermore, improving technological advancements, the rising prevalence of male infertility and modernization in the healthcare sector, and growing research and development activities in the healthcare sector create new opportunities for market growth during the forecast period. Concerning IVF, IUI is a more straightforward procedure to execute. IUI is relatively less invasive and less expensive; however, the success rates associated with IUI are not very promising. Improvement, regulation, and standardization of IUI procedures are expected to boost the growth of this technique.
IVF without ICSI is the second largest segment. Fertility rates are witnessing a continuous decline throughout the world. Estimates from the United Nations Department of Economic and Social Affairs, World Population Prospects (2017) suggest that the global fertility rate has declined drastically in the past two decades. Couples seeking parenthood are most likely to choose conventional IVF treatment to conceive, thereby creating prospects for market growth.
Intrauterine Insemination (IUI) is the third largest segment. An increase in cases of infertility being reported across developed and developing economies coupled with several initiatives by government and private organizations for spreading awareness about sexual and reproductive health are the major factors that drive the growth of the global market. In addition, increased consumption of various medicines is another significant factor anticipated to boost the development of the intrauterine insemination (IUI) market during the forecast period.
Based on service, the global fertility services market is categorized into Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor, and Frozen Donor.
The Fresh Non-Donor segment is a significant revenue contributor and is estimated to grow at a CAGR of 16.4% during the forecast period due to the preferable use of this technique. Delayed pregnancy trends in women, technological advancements, advantages of fresh embryo transfer over the frozen embryo technique, increased rate of infertility, and higher success rate of this technique are the primary drivers of the fresh non-donor segment.
The Egg & Embryo Banking segment is the fastest growing. The egg and embryo banking segment is estimated to exhibit significant market growth during the forecast period due to the increasing popularity of egg freezing. Key advantages offered by egg freezing techniques, such as lesser stress, lower cost, and convenience, further contribute to the market growth. On the other hand, few embryos do not withstand the thawing procedures, and the cryo-damage is expected to hamper the development of the egg and embryo banking segment.
Frozen Non-Donor is the third-largest segment. Lesser stress, lower cost, and convenience offered by the frozen embryo IVF technique fuel its need, thereby boosting the growth of the fixed non-donor market. In addition, this technique can be used in women who develop cancer after a successful IVF procedure and women who cannot reproduce their eggs. However, few embryos do not withstand the thawing procedures, and the cryo-damage can adversely affect the embryo quality, negatively impacting this segment's market growth.
Based on end-user, the global fertility services market is segmented into Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes.
The Fertility Clinics Segment holds the highest share of the global fertility services market and is estimated to grow at a CAGR of 15.3% during the forecast period. The rise in the number of fertility clinics across the globe, coupled with technological advancements, are the factors expected to boost the growth of the global market during the forecast period. Moreover, awareness among the people in developed and emerging economies regarding infertility treatment is experiencing a rapid increase. This has resulted in an increased number of fertility treatment clinics worldwide, which is anticipated to boost the growth of the global market.
Hospitals provide a variety of fertility treatments for patients worldwide. Alliance with the academic institutes/universities and availability of government funding are the major factors that drive the growth of the hospital end-user segment. This segment includes the treatment centers that not only provide IVF treatments but also cater to a wider variety of other treatments unrelated to IVF. Many hospitals provide basic fertility tests and counseling that require reproductive assisted technology (ART) procedures, especially IVF intervention. Hence, it is anticipated to boost the demand for fertility services and drive market growth.
Surgical Centers are expected to be the fastest-growing segment. Surgical centers offer numerous surgical procedures for the treatment of infertility. For instance, different surgical sperm removal methods, such as percutaneous epididymal sperm aspiration (PESA), microsurgical epididymal sperm aspiration (MESA), testicular sperm aspiration (TESA), testicular sperm extraction (TESE), and others, are provided by surgical centers.
Based on regions, the global fertility services market share is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional Growth Insights Request Sample Pages
Asia-Pacific holds the leading position in the global market. It is also expected to be the fastest-growing region, growing at a CAGR of 18.3% during the forecast period. Due to the region's rising infertility rate, a tendency toward later-term pregnancies, an explosion in IVF success rates, and an increase in disposable income, the Asia-Pacific IVF services market is predicted to develop significantly throughout the forecast period. One of the extensively utilized methods for helping persons with infertility issues, including couples, single mothers, and members of the LGBT community, is in vitro fertilization (IVF). Additionally, the market for IVF treatments in Asia-Pacific has sustained development potential due to the surge in fertility tourism. Future market growth for reproductive services is also anticipated to be boosted by a rise in fertility clinics and expansion potential in emerging regions.
North America is the second-largest region and is projected to reach USD 9,110 million, growing at a CAGR of 13.6% during the forecast period. It presents abundant opportunities for players operating in the market, owing to its high population base, growth in knowledge about fertility treatment, rise in popularity of IVF in the US, increase in the rate of infertility and practices of embryo banking cycles, technological advancements, and delayed pregnancy trends. The rate of fertilization with IVF in the age range of 35 to 39 years is reportedly very high, according to the Centers for Disease Control and Prevention (CDC). The reproductive system's inability to create completely formed eggs for fertilization increases the chance of genetic diseases in the egg in older women (those over the age of 40). Additionally, older people have a decreased ability to produce quality eggs and a higher risk of miscarriage. Thus, it is projected that an increase in the tendency of women to delay childbearing will fuel the market for fertility services.
Europe houses 40% of the world's IVF clinics, which has proved to be a significant contributor to the success of the European infertility testing and treatment market. The region has also witnessed substantial investments from global market leaders. The overall outlook for the European market looks promising as its superior IVF technology attracts considerable investments from private equity investors. Also, DIY testing has increased access and helped reduce the costs of infertility testing and treatment. Both these factors provide lucrative opportunities for fertility services market growth.